LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$3.19
−3.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.42x
- Price / sales
- 34.64x
- Price / cash flow
- -0.90x
Enterprise value
- Enterprise value
- $2.8M
- EV / sales
- 14.41x
- EV / EBITDA
- -0.36x
- EV / EBIT
- -0.36x
- Market cap
- $6.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of May 1, 2026